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ABSTRACT
Objectives To explore the attitudes, views and
understanding of women attending a Hindu
temple in London, UK towards cervical screening,
human papillomavirus (HPV) testing and two
HPV self-sample collection devices: the Dacron
swab and Evalyn® brush.
Methods A mixed methods design comprising a
survey and four focus groups was adopted.
Focus group discussions were recorded and
transcribed verbatim and explored using thematic
framework analysis.
Results A total of 185 Hindu women completed
surveys and 23 attended focus groups. Of the
respondents 75% aged 25–64 years reported
having cervical screening within the last 5 years;
85% had attended college or university. Familiar
barriers to attendance for screening were
identified: fear of pain and the test result,
embarrassment, screener’s attitude, inconvenient
appointment times and difficulty with child care.
Additional barriers cited included age and
country of birth, with older and Indian-born
women thought to be less likely to attend for
screening. Self-collected sampling had a mixed
reception. Women were not confident that their
sample would be as good as a clinician sample
and expressed concern about the impact that a
positive HPV result might have on their
relationships.
Conclusions Screening attendance in this highly
educated group of Hindu women was slightly
lower than in the general population (75% of
women aged 25–64 years had been screened in
the last 5 years compared with 79% in England
as a whole). Familiar barriers to screening were
identified. Women felt able to collect their own
sample for HPV testing with a Dacron swab but
lacked confidence that it would be as good as
that obtained by a clinician.
INTRODUCTION
The National Health Service Cervical
Screening Programme (NHSCSP) in
England invites all women registered
with a general practitioner (GP) aged 25–
49 years and 50–64 years to attend for
free cervical screening, every 3 or
5 years, respectively. The stated target, to
ensure that 80% of women are screened,1
has not been achieved in recent years.2 In
2011–2012 only 78.6% of women were
screened at least once within the last
5 years.3 Women aged under 50 years
were less likely to attend within 3.5 years
when invited (73.5%) but more likely to
have attended by 5 years (79%).1–5
Inequalities in the uptake of cancer
screening by ethnic minority populations
have been well documented,6–12 as has
the association between poor uptake and
social deprivation.1 13 14 Education and
ethnicity have been shown to be
Key message points
▸ Screening attendance in these highly
educated Hindu women is less than in
the general population.
▸ This population would currently prefer
cervical smear tests as a positive
human papillomavirus (HPV) test may
cause relationship problems and HPV
infection is untreatable.
▸ These women had more confidence in
a doctor’s sample than their own, but
believe younger women would have
more confidence.
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predictors of attendance for cervical screening, with
increased likelihood of attendance among more highly
educated women and white British women.7 15 16
Populations are diverse and so exploring subgroups
within them may provide further information regard-
ing uptake of cervical screening. In the 2011 census,
1.5% of the population of England and Wales were
recorded as Hindu (816 633).17 In addition, 58% of
Hindus in 2001 were women aged 25–64 years and
likely to be eligible for cervical screening.18 Of the
Hindus in England 52% live in London, with Harrow
and Brent in North West London containing the
highest proportions of any of the London boroughs
(20% and 17%, respectively).19
Reasons frequently given for not attending for cer-
vical screening include the nature of the examination
resulting in embarrassment and fear of pain20 21; prac-
tical issues with child care or absence from work, and
concerns around the gender of the sample taker.
Given the choice between a male or female GP, non-
white women have been shown to be more likely than
white women to say that they would prefer a female
GP (42% vs 29%).22
Human papillomavirus (HPV) is a common sexually
transmitted virus. Persistent infection with oncogenic
HPV types is associated with an increased risk of cer-
vical cancer.23–25 HPV testing therefore has a place in
the field of cervical cancer prevention and, unlike cer-
vical cytology, is proving to have great potential as a
test using samples that women collect themselves and
potentially in the privacy of their own home.26–28
Self-collected sample testing has been shown to have
similar specificity and sensitivity to clinician sampling
and is more sensitive than cytology.29–31 A test that
removes some of the barriers to the uptake of cervical
screening could be of benefit32 but it is important to
recognise that the detection of this sexually transmit-
ted virus may have adverse implications, particularly
within some religious groups.33
It has been reported that women find self-collected
sampling acceptable.26 30 34 35 There is some evidence
that women from ethnic minority groups may be
willing to collect their own samples, but Indian and
Pakistani women were less certain about this than
white British women.36 There is scant published
research regarding cervical screening uptake and
women’s religion. Of the Indian population in the UK
approximately 45% is Hindu.18 This research group
has previously explored the attitudes and understand-
ing of Muslim women towards cervical screening,
HPV testing and self-collected samples.37 Religious
networks are a useful route by which health messages
can be disseminated to populations where screening
uptake may be low.
OBJECTIVES
To explore the attitudes and understanding of Hindu
women towards cervical screening, HPV testing and
self-collected HPV samples and to ascertain their
views on two different self-collection devices: the
Dacron swab and the Evalyn® brush.
METHODS
Participants and recruitment
Hindu women were recruited at an Open House
Weekend Event in September 2011 and a Health and
Vitality Day for ‘Yuvati’ (women aged under 40 years)
in January 2012 organised by members of BAPS Shri
Swaminarayan Mandir. Popularly known as the
‘Neasden Temple’, it is a place of worship for Hindus
living in and around London and is located in the
London Borough of Brent
Ethical approval
The study was approved by the UCL Research Ethics
Committee.
Procedure
A mixed methods design was adopted using a survey
(see online Supplementary Figure 1) and four focus
group discussions (Figure 1).38 Women were
approached at the above-mentioned events and were
asked if they would complete a survey with the aim of
gathering baseline data on screening attendance and
demography. They were asked to provide contact
details if they were interested in participating in focus
group discussions. Of those returning the survey, 114
women consented to being contacted. A further seven
were discounted as they did not indicate that they
were Hindu, 31 were either too young or did not
provide their age and seven provided illegible details.
Those interested were subsequently contacted and
invited to attend one of four focus group discussions
held at the Mandir. The intention was to purposively
sample if sufficient women agreed to participate.
‘Snowball sampling’ (i.e. using participants to recruit
others) was incorporated into the recruitment process.
Women participating in the focus groups were asked
to sign an informed consent form and were given £20
towards their time and travel costs. A donation was
given to the BAPS Shri Swaminarayan Mandir in
acknowledgement of their assistance and the facilities
provided. Two researchers ( JW and LC) moderated
one and three focus groups, respectively.
Representatives from the Mandir recommended that
the groups be held in English with any translation
being done within the group, as an outside translator
could inhibit participants. Focus group discussions
(lasting 45–60 minutes) were audio recorded and
notes taken by LAB. During the discussions partici-
pants were given an information leaflet about HPV
and Evalyn brush collection kits followed by Dacron
swab collection kits, both with instructions. The
Dacron swab resembles a cotton bud, approximately
15 cm long, which is inserted into the vagina and
rotated for approximately 20 seconds. It is then
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broken off into a small tube with approximately
0.5 ml liquid specimen transport medium. The Evalyn
brush consists of a pink stick with a brush at one end
and a plunger at the other and is approximately
20 cm long. The cap is removed, the stick is inserted
into the vagina, the plunger pushed to reveal the
Figure 1 Topic guide for focus group discussions.
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brush, which is rotated five times and removed. It is
then retracted into its plastic tube and the cap
replaced.
Analysis
The survey data were entered onto a Microsoft Office
Access 2007 database. STATA/IC 12.1 was used for
statistical analysis. Initial results were tabulated and
formal statistical comparisons were made using the
Chi-square (χ2) test and multivariate analyses using
logistic regression. The focus group discussions were
transcribed verbatim (LAB) and were analysed
together with field notes. Recurrent themes were
identified and organised into a matrix for framework
analysis.38 Five main themes and twenty subthemes
were identified (see online Supplementary Figure 2).
Framework analysis was performed by both LC and
LAB and any discordance was resolved by discussion.
RESULTS
Sample
Surveys were returned by 204 women (see online
Supplementary Table 1) with 19 being excluded as
they did not state that they were Hindu. Of the
remaining 185 surveys, 45 women omitted their age,
five of whom were among the 23 women who partici-
pated in focus group discussions (Figure 2) (see online
Supplementary Table 1). Of those returning a survey,
114 women consented to being contacted to partici-
pate in focus group discussions, of whom 49 were dis-
counted as they did not indicate that they were
Hindu, were either too young or did not provide their
age or provided illegible details. Of the remaining 65,
18 could not be contacted or declined, leaving 31
women. This meant that purposive sampling was not
realistic.
Ethnic background was described as Indian by 92%
of respondents. Of those aged 25–49 years who
answered the question, 64% had had cervical screen-
ing within 3 years, but this figure rose to 75% for
screening within 5 years. In women aged 25–64 years,
76% reported attendance within 5 years (Table 1).
The women did, however, seem to be relatively
regular attenders, with 40% of women aged 50–64
years having had more than three lifetime screens
(Table 2).
Only 4% (n=5) of women aged 25–64 years indi-
cated that they did not know about cervical screening,
four of whom had been in the UK for less than
6 years.
Excluding women outside the recommended screen-
ing age, when exploring attendance for screening
within the recommended interval (within 3 years for
women aged 25–49 years and within 5 years for
women aged 50–64 years), women who were single
were significantly less likely than women who were
married, living with a partner, divorced, separated or
widowed to have attended [OR 0.19, 95% confidence
interval (CI) 0.05–0.70]. This result remained signifi-
cant after adjusting for age (OR 0.21, 95% CI 0.06–
0.83). Additional adjustment for educational level did
not affect these results.
Screening attendance within the recommended
screening interval decreased with increasing level of
education, with 77% (n=13/17) of women not going
onto further education attending compared to 56%
(n=57/101) of those who did. This, however, was not
statistically significant (p=0.12).
Figure 2 Age comparisons of the survey and focus groups.
Table 1 Years since last screening by age (where given)
Age group (years)
Time since last smear [n (row %)]
Never 0–3 years 4–5 years >5 years Total
<25* 22 (92) 1 (4) 1 (4) 0 (0) 24
25–49 19 (23) 54 (64) 9 (11) 2 (2) 84
50–64 1 (4) 12 (48) 7 (28) 5 (20) 25
>64* 1 (100) 0 (0) 0 (0) 0 (0) 1
Total 43 (32) 67 (50) 17 (13) 7 (5) 134
*Not eligible for routine screening. The National Health Service Cervical Screening Programme invites women aged 25–49 years to attend for routine
screening every 3 years and those aged 50–64 years every 5 years.
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Notably, 85% of respondents to the question indi-
cated that they had attended college, university or
undertaken postgraduate study (Table 3). Country of
birth was statistically significant as a predictor of
attendance for screening (p=0.024), with women
being born other than in England or India more likely
to attend within the recommended screening intervals.
Parity was also significant as a predictor of attendance
(p=0.037). Never having had sexual intercourse, not
knowing about cervical screening and not considering it
important, although statistically significant as predictors
of attendance, were too few to be considered reliable.
Some 21% of Hindu women returning surveys indi-
cated they were afraid of pain, 17% were embarrassed
and 8% were fearful that they would be told they had
cancer.
QUALITATIVE RESULTS
Understanding of cervical smear test
Although there was some confusion about whether
cervical screening was also to “check the womb; and
ovaries” [Participant 90 (P90)], overall women in the
focus groups showed a good understanding of the
purpose of the test. Some of the participants were
clear that it was “to see if there’s any abnormal cells”
(P106) to detect whether one had a chance of getting
cancer and to increase the chances of being able to
treat this in the earlier stages. Some described the
screening programme as for women “maybe married,
unmarried if they are having a relationship” (P202).
There was an acknowledgement of the association
with sexual activity and that sex outside marriage may
occur.
Barriers to attendance for cervical screening
Familiar barriers to attendance were confirmed by the
focus group discussions: inconvenient appointment
times, difficulty with child care, fear of pain, embar-
rassment, the sample taker may be male, the sample
taker’s attitude “they get angry and then you become
more tense” (P90) and “some people don’t go because
of the frightening news they might get” (P105).
Further barriers to attendance identified within the
focus group discussions were age and country of
birth: “a lot of the older generation, the ones that are
not well educated, don’t bother” (P134). Participants
said that in the case of their mothers: “They’re
brought up in India, they hardly take orthodox
medicines or hospitals and clinics … no awareness
about their health, I’m sure they were not even edu-
cated they didn’t go to schools … so nobody told
them about all this” (P90). Also “that generation felt
that … if they die it is just destiny” (P103).
HPV awareness
Some women knew of HPV because of the vaccine
and associated news stories: “there was a girl who had
that kind of vaccine and she was in a coma” (P106).
Some were aware that the vaccine was prophylactic
and had to be given to young girls “because they are
not in a relationship” (P202). There was limited dis-
cussion around HPV and cervical cancer, with one
participant saying “No, no, no; HPV is not related to
cancer” (P197) and another that it must be transmit-
ted “from the partner probably” (P202).
Acceptability of HPV self-collected sample testing
Self-collection or clinician sample preference
Women were positive about the HPV self-collected
sampling but comments were weighted towards pre-
ferring to have a test done at their doctor’s surgery:
“It [HPV self-collected sample] saves you going, saves
you embarrassment … if you haven’t got time to go
… I would rather do it at the doctor” (P202). Their
concerns stemmed from lack of confidence that they
had done the test correctly: “prefer doctor’s test
because they are perfect and we are not perfect”
(P204). An increased screening interval if HPV testing
was adopted did not have any significant appeal: “it’s
not worth it” (P201).
Differences between generations
Regarding younger women, “I think they’ll be fine
they are really quite forward” (P120) but “the older
generation they wouldn’t know how to do it. It would
be like a bit frightening for them” (P120). Also that
widows “won’t even bother I think … for them they
are like more in grief really at that point”. They will
just say “… let’s ignore it we are not having sex”
(P106). They felt it would be more appropriate for
them to collect and return samples to the GP rather
than receive them at home. One participant, however,
felt strongly that “I know my daughter … she would
rather go to the GP than do this, … she would find
that really dirty having to do that herself” (P103).
Effect of an HPV-positive result
It was expressed that “If you know you are positive
then it disturbs your relationship with your partner
and if there is no treatment then there is no point in
having it” (P197). Countering this, however, were the
views expressed that “it is up to the individual … you
have got to have trust in every marriage … not just
me but my husband as well” (P134).
It was felt by some that HPV disclosure would not
be such a problem for the younger generation: “they
are broad minded, they are not like us … if someone
Table 2 Number of lifetime screening tests by age group
Age group (years)
Total number of lifetime smears [n (row %)]
0 1 2–3 >3 Total
25–49 19 (23) 24 (29) 17 (20) 24 (29) 84
50–64 0 (0) 5 (20) 10 (40) 10 (40) 25
Total 19 (17) 29 (27) 27 (25) 34 (31) 109
Pearson Chi-square (χ2) (3)=10.03; p=0.18.
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Table 3 Survey response by screening attendance
Attendance for screening within recommended intervals (i.e. age 25–49 years within
3 years, 50–64 years within 5 years) [n (row %)]
Not attended Attended Total
Total aged 25–64 years 36 (33) 73 (67) 109
Ever had an abnormal smear result
Yes 0 (0) 4 (100) 4
No 20 (24) 63 (76) 83
p=0.19
Parous
Yes 21 (26) 59 (74) 80
No 13 (50) 13 (50) 26
p=0.037
Country of birth
UK 9 (38) 15 (63) 24
India 15 (40) 23 (61) 38
Other 7 (28) 18 (72) 25
p=0.024
Years lived in the UK
<6 8 (40) 12 (60) 20
7–20 6 (35) 11 (65) 17
>20 22 (31) 50 (69) 72
p=0.71
Stage at which education was completed
No response 3 (50) 3 (50) 6
Before secondary school 0 (0) 2 (100) 2
Secondary school 2 (15) 11 (85) 13
College or university 20 (34) 39 (66) 59
Postgraduate 11 (38) 18 (62) 29
p=0.42
Reasons for not going for a smear test
Does not know about smear tests
No response 32 (31) 72 (69) 104
Yes 4 (80) 1 (20) 5
p=0.022
Embarrassment
No response 30 (33) 61 (67) 91
Yes 6 (33) 12 (67) 18
p=0.97
Fear of cancer
No response 32 (33) 66 (67) 98
Yes 4 (36) 7 (67) 11
p=0.80
Fear or pain
No response 27 (30) 63 (70) 90
Yes 9 (47) 10 (53) 19
p=0.14
No problems in that area that need checking
No response 31 (31) 70 (69) 101
Yes 5 (63) 3 (38) 8
p=0.066
Continued
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knows or not they don’t worry” (P196); “in our gen-
eration you never expect that your partner will be
liaising with somebody else” (P197).
With regard to the wider family: “it’s up to them to
sort it out. … it is up to them I can’t get involved in
that” (P202). However, some women felt “the same
thing is with the children also … because you have
lost the trust” (P197).
Women commented that they would find a positive
result “frightening” and that “they shouldn’t … come
out with a letter to say you’ve got this virus. They can
say go to your GP” (P103).
Acceptability of the HPV self-collection devices and the
instruction sheets
Women felt able to use the Dacron swab and instruc-
tions despite some concerns that “it did break easily”
(P90) and it could be lost inside them. Overall it was
considered “much easier; everyone can do it, even
older generation women they don’t know how to read
or write even so even they can do it” (P120). The
Evalyn brush, however, was not so well received: “this
one is too big and painful [Evalyn brush]; this one
[Dacron swab] is small, this one is good, easier”
(P204) and it was a “bit complicated, isn’t it?; there is
so many things we have to do” (P87).
DISCUSSION
This is the first study looking specifically at Hindu
women in England and attendance for cervical screen-
ing. Hindus in the UK are moderately diverse in terms
of deprivation with 7% living in the lowest decile of
housing deprivation areas and 7% in the most advan-
taged decile.39 The participants in this small study
Table 3 Continued
Attendance for screening within recommended intervals (i.e. age 25–49 years within
3 years, 50–64 years within 5 years) [n (row %)]
Not attended Attended Total
Total aged 25–64 years 36 (33) 73 (67) 109
Appointment times are not suitable/convenient
No response 31 (31) 70 (69) 101
Yes 5 (63) 3 (38) 8
p=0.006
Not important
No response 32 (31) 72 (69) 104
Yes 4 (80) 1 (20) 5
p=0.022
Information is too complicated
No response 36 (33) 72 (67) 108
Yes 0 (0) 1 (100) 1
p=0.48
Problems arranging child care
No response 31 (31) 69 (69) 100
Yes 5 (56) 4 (44) 9
p=0.13
Does not know anyone who goes for smear tests
No response 34 (32) 73 (68) 107
Yes 2 (100) 0 (0) 2
p=0.42
Never had sexual intercourse
No response 29 (29) 72 (71) 101
Yes 7 (88) 1 (13) 8
p=0.001
Previous surgery and does not need a smear test
False 35 (32) 73 (68) 108
True 1 (100) 0 (0) 1
p=0.15
Always go for smear tests when invited
False 32 (41) 46 (59) 78
True 4 (13) 27 (87) 31
p=0.005
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represent well-educated Hindu women with an above-
average education profile. Only 15% had not contin-
ued onto further education at a college or university
compared with 39% of the Hindu population of
England and Wales.18 The evidence from this study,
however, does not support the hypothesis that a well-
educated cohort would be more likely to attend for
cervical screening than the general population, with a
5-year attendance rate for cervical screening of 75%
vs 78.6% in the general population. This, may,
however, simply be a fact of being Hindu rather than
educational level.
Barriers to screening attendance were similar to
those of other populations. It was suggested that the
older generation of Hindu women (mothers and
mothers-in-law) would be less likely to attend for
screening or to collect a sample themselves, espe-
cially if they were born in India where there may
have been less exposure to health care or education.
This view on cervical screening attendance was not,
however, totally borne out in this study. Within this
group of women, 76% of those aged 50–64 years
reported having had cervical screening within the
last 5 years, and attendance for screening in accord-
ance with recommended screening intervals was
similar in women born in India and the UK (61% vs
63%).
With regard to self-collected samples for HPV
testing, women accepted the Dacron swab collection
device and instructions but were all unenthusiastic
about the Evalyn brush, believing that not only was
it big but they did not think that they would be able
to use it. They were positive towards self-collected
sampling but still expressed a preference to attend
for testing at their GP surgery as they would have
more confidence in the reliability of their GP’s
sample than their own. They were also reluctant to
receive a positive HPV result, due to it being a sexu-
ally transmitted infection that could not be treated,
and the impact this might have on the trust within
their relationships.
Limitations
The quantitative part of the study involved a relatively
small sample size, further reduced by a number of
incomplete surveys. In addition, for simplicity, women
were asked about their screening attendance within
the last 3 years, whereas the NHSCSP reports cover-
age within the last 3.5 years, so the figures are not
strictly comparable. In addition, women were
recruited at health-related events, which might mean
they were more engaged with health issues than the
wider Hindu population in London.
There are limitations associated with holding focus
group discussions within community groups. There
may be concerns within the group around confidenti-
ality despite clearly stated ground rules. Pragmatism
meant that this was the most practical approach
however.
It is recognised that by participating in research
around cervical screening there may be a bias towards
women who have attended for cervical screening and
so the women are not necessarily representative of the
Hindu population as a whole. There would be further
self-selection by those women agreeing to participate
in focus group discussions. This population in particu-
lar may not be representative of all Hindus in the UK.
CONCLUSIONS
It is hard to extrapolate the evidence gathered in this
study to the Hindu population of England as a whole
because it is a diverse population whereas this study
population seems less so. However, the message these
women are communicating is similar to that of other
communities (e.g. Muslim37). They prefer to attend
for cervical screening performed by a female profes-
sional than collect a sample themselves. Therefore,
before self-sampling could be introduced on a larger
scale efforts would need to be made to build the con-
fidence of women regarding the quality of the sample
they could collect and to address anxieties surround-
ing being told that they had an untreatable sexually
transmitted infection. With regard to collection
devices, as shown in previous research by this group,
women find the Dacron swab the most acceptable
device.
It would be useful to explore these issues further in
harder-to-reach Hindu groups including those from
less-educated backgrounds or those who do not attend
for cervical screening. It would also be useful to
explore methods of disseminating information around
HPV and cervical cancer prevention within Hindu
religious organisations and groups.
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